Press releases

Varian and Siemens Healthineers Recognized in Survey of U.S. Radiation Oncology and Diagnostic Imaging Professionals

Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak™ report on industry leaders in diagnostic imaging equipment in the United States. Varian ranked...

Varian and Icon Oncology Partner to Establish Value-Based Cancer Treatment Hub for Southern Africa

Varian, a Siemens Healthineers company, announced today an agreement with Icon Oncology, South Africa's leading oncology provider, that will enhance access to cancer care through a value-based...

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer

Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center today announced the completion of enrollment in FAST-01 (FeAsibility Study of FLASH...

News Items

Varian Installs Cyclotron at National Taiwan University Cancer Center

Installation marks milestone for first ProBeam system in Taiwan Varian announced the installation of the cyclotron for its ProBeam® proton therapy system at the National Taiwan University Cancer Center (NTUCC). The cyclotron is a core piece of…

Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients

Varian announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology. Cancer is the leading…

Varian Partners with Sony Foundation Australia in the You Can Stay Program

Varian announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families in Australia who…

Blog posts

Two Decades and 15,000 Cancer Patients Later, a Clinac® 2300 Retires


After 20 years and having been used to treat approximately 15,000 cancer patients, a Clinac 2300 at the National Cancer Institute José Alencar Gomes da Silva (INCA) in Rio de Janeiro, Brazil, has been deactivated.

Read more

Combining Immunotherapy with Stereotactic Radiotherapy: A Paradigm Shift?


In a VarianVision webinar held in early 2021, expert oncologists from the University of California at San Diego Moores Cancer Center discussed how advances in combining immunotherapy with stereotactic radiotherapy may be leading to a paradigm shift in the...

Read more

Multidisciplinary Cancer Care: What Does the Future Hold?


The use of multidisciplinary collaboration through tumor boards leads to changes in diagnosis, treatment, and survival, and it is the best way to deliver the complex care needed by cancer patients, according to recently published long-term research.

Read more

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos™ therapy
Ethos™ therapy